Prof Roger Barker, University of Cambridge

Prof Roger Barker

University of Cambridge


Roger Barker is Professor of Clinical Neuroscience and Honorary Consultant in Neurology at the University of Cambridge and at Addenbrooke's Hospital.  He trained at Oxford and London and has been in his current position since 2000, after completing an MRC Clinician Scientist Fellowship.

Roger combines basic research looking at novel therapies to treat chronic neurodegenerative disorders of the brain with clinically-based work aimed at better defining such disorders. He is the co-ordinator of the TRANSEURO project looking at fetal cell grafting in patients with early Parkinson's Disease and is part of the GFORCE PD initiative as well as Director of the International Society for Stem Cell Research.

Dr Zoe Hewitt, University of Sheffield

Dr Zoe Hewitt

University of Sheffield

Project Manager
+44 (0)114 2222355

The Scientific Advisory Board (SAB) for the Pluripotent Stem Cells and Engineered Cells (PSEC) includes senior academic, industrial and regulatory experts to provide independent advice regarding the Hubs activities and future strategy to ensure scientific excellence.

The goal of the SAB is to steer and challenge the Hub in its development and delivery of our scientific and translational objectives. The PSEC Advisory Board consist of the following members:



Prof Kevin Eggan
Department of Stem Cell and Regenerative Biology, Harvard University


Prof Paul Fairchild
Sir William Dunn School of Pathology, University of Oxford

Prof Jack Price
Head of Advanced Therapies, NIBSC UK Stem Cell Bank

Dr Jacqueline Barry
Chief Clinical Officer, CGT Catapult

Dr Andreas Bosio
Senior Manager Research and Development, Miltenyi Biotec

Dr Julian Braybrook
Director of Measurement Science and Partnerships, Science and Innovation, at LGC

Dr Steve Howe
Head, Cell and Gene Therapy Process Research, GSK